Compensation Guidelines

All mentors at the University of Alabama at Birmingham are strongly encouraged to follow the National Institutes of Health, National Research Service Award (NRSA) stipend level guidelines.

The current compensation amounts for years of experience can be found at

http://grants.nih.gov/grants/guide/notice-files/NOT-OD-14-046.html

If it is impossible to fund according to the NRSA guidelines, the minimum starting salary at UAB is $35,190.00 (effective Oct. 1, 2011) plus benefits.

 

UAB News

  • Bluesman Keb’ Mo’ will take the stage first at 7 p.m., with alternative hip-hop  rockers G. Love & Special Sauce performing the second set.Keb' Mo'The University of Alabama at Birmingham’s Alys Stephens Performing Arts Center will present Keb’ Mo’ and G. Love & Special Sauce on Tuesday, Aug. 26. The two bands will perform as co-headliners; each will perform a separate set, with Keb’ Mo’ first. The show is set for 7 p.m., in the ASC,...

  • The Quad Rider makes it easy to shift gears and brake, enabling people with poor grip-control to safely cycle.The University of Alabama at Birmingham and the Lakeshore Foundation are partnering with InvoTek, Inc., to create a gear and braking device that helps people with disabilities who have limited or no use of their hands operate a handcycle safely. InvoTek, a research and development company in Alma, Arkansas, has received a $175,000 Phase I Small Business Innovation...

UAB Research News

  • The Quad Rider makes it easy to shift gears and brake, enabling people with poor grip-control to safely cycle.The University of Alabama at Birmingham and the Lakeshore Foundation are partnering with InvoTek, Inc., to create a gear and braking device that helps people with disabilities who have limited or no use of their hands operate a handcycle safely. InvoTek, a research and development company in Alma, Arkansas, has received a $175,000 Phase I Small Business Innovation...

  • New drugs to slow or even prevent Parkinson’s could be in human studies as early as 2015.Written by Matt Windsor An enzyme closely associated with genetic forms of Parkinson’s disease appears to play a larger role in its progression than previously thought, say investigators at the University of Alabama at Birmingham. The new research offers encouraging evidence that drugs to block this enzyme, known as leucine-rich repeat kinase 2 or LRRK2, could slow — or even...